-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Aerie Pharmaceuticals Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2021.
- Aerie Pharmaceuticals Inc Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2022 was -$26.8M, a 32.4% increase year-over-year.
- Aerie Pharmaceuticals Inc Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2022 was -$36.6M, a 78% increase year-over-year.
- Aerie Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$74.8M, a 59.1% increase from 2020.
- Aerie Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2020 was -$183M, a 8.26% increase from 2019.
- Aerie Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2019 was -$200M, a 14.2% increase from 2018.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)